This is a non-core endpoint: only basic statistics are computed.
Lymphocyte function antigen-1 [LFA-1] defect
D3_LYMPHOANTIGEN1DEF
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
32
Check minimum number of events None
32
Include endpoints None
32
Remove individuals based on genotype QC
32
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Lymphocyte function antigen-1 [LFA-1] defect based on the number of shared cases.
Broader endpoints:
- Other immunodeficiencies
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 32 | 15 | 17 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
Mean age at first event (years) | 66.46 | 62.01 | 70.38 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: D3_LYMPHOANTIGEN1DEF – Lymphocyte function antigen-1 [LFA-1] defect
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Lymphocyte function antigen-1 [LFA-1] defect
↥Endpoint not on priority list, no data to show.